News

Impact of Azacitidine Maintenance Therapy on Survival of Patients with AML in Remission Depending on Initial Chemotherapy
The QUAZAR AML-001 study showed that oral azacitidine maintenance therapy significantly prolongs relapse-free survival (RFS) and overall survival (OS) in patients with acute myeloid leukemia (AML) in first remission after intensive chemotherapy (including induction ± consolidation therapy), who are not candidates for hematopoietic stem cell transplantation (HSCT), compared to placebo. In October 2023, results of a subgroup analysis of patients stratified according to the use/non-use of consolidation chemotherapy and the number of consolidation…

Doc. Milan Sova: AAT substitution is available to all indicated patients. It is therefore crucial to now educate about the necessity of regular treatment

Anabolic Antiosteoporotic Treatment as a First Step in Patients with Very High Fracture Risk

Cardio-renal-metabolic syndrome in context

MUDr. Petra Garnolová: The combination of medical cannabis with other analgesics is the ideal way to achieve the best effect with the fewest side effects

Calculator Naxiva - Application for Easy Prescription of Medical Cannabis Extracts

A Decade of Therapy Targeting B Lymphocytes in MS

Diagnosis and Management of Interstitial Lung Processes Associated with Rheumatoid Arthritis

Potential of Enoxaparin to Maintain A-V Shunt Patency According to the SEP Protocol

How to Navigate the Challenges of Anticoagulant Therapy in Pregnant Women − A Case Study
Conferences
News from the world of medicine
All conferences
Popular this week
- Shooting at the Faculty of Arts of Charles University and activation of the trauma plan at the First Surgical Clinic of the General Teaching Hospital
- BENIGN DERMATOSIS OF PENIS
- Does AI Evaluate Patients' Health More Accurately Than Doctors?
- Brain scans of patients with multiple sclerosis will be evaluated by AI
- The Contribution of Flexible 3D Bone Models for Surgical Training and Planning